Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Investors Seek Array Of Nanotechnology Projects To Finance

This article was originally published in The Gray Sheet

Executive Summary

Health care nanotechnologies continue to be a hot prospect for venture capitalists and other investors, said investment managers March 26 at the PharmaMedDevice combination products meeting in Philadelphia

You may also be interested in...



FDA Continues Nanotech Policy Development With September Meeting

FDA will hold a meeting next month to hear opinions on new guidelines in development on nanotechnology products, the agency announced Aug. 7 in the Federal Register

FDA Continues Nanotech Policy Development With September Meeting

FDA will hold a meeting next month to hear opinions on new guidelines in development on nanotechnology products, the agency announced Aug. 7 in the Federal Register

FDA Prepares To Issue Regulatory Guidance For Nanotechnology Devices

FDA should develop guidance for products that use nanotechnology and take steps to address the risks and benefits of the emerging technology, a July 25 agency task force report recommends

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025970

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel